Analystreport

Jounce Therapeutics Inc (NASDAQ: JNCE) had its price target raised by analysts at HC Wainwright from $8.00 to $9.00. They now have a "buy" rating on the stock.

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com